心血管指南

订阅

MedSci主页 / 所有栏目 / 心血管指南

规范应用心肌肌钙蛋白和利钠肽现场快速检测专家共识（2020 年）

2020-11-30 国家心血管病中心 中国循环杂志.2020.35(11):1045-1051.

肌钙蛋白

国内外多部指南建议使用心肌肌钙蛋白（cTn）和B 型利钠肽（BNP）/N 末端B 型利钠肽原（NT-proBNP）用于急性冠状动脉综合征（ACS）和急、慢性心力衰竭的诊断、鉴别诊断和危险分层，以指导相

中文标题：

规范应用心肌肌钙蛋白和利钠肽现场快速检测专家共识（2020 年）

发布机构：

国家心血管病中心

发布日期：

2020-11-30

简要介绍：

国内外多部指南建议使用心肌肌钙蛋白（cTn）和B 型利钠肽（BNP）/N 末端B 型利钠肽原（NT-proBNP）用于急性冠状动脉综合征（ACS）和急、慢性心力衰竭的诊断、鉴别诊断和危险分层，以指导相关治疗。鉴于胸痛和胸痛等同症状以及胸闷（呼吸困难）是心血管病患者常见症状，而现场快速检测（point-of-care testing,POCT）具有仪器小型化、操作简单化、结果报告即时化（2~10 min 内提供结果）、不受时间与地点限制等优势，本共识优先推荐特异度和灵敏度都较好的POCT 技术检测cTn 和BNP/NT-proBNP 分别作为怀疑ACS 和心力衰竭患者在适宜临床情况下的初诊检测项目。但POCT 在快速获得测试结果、检验周转时间短的情况下，可能会牺牲部分结果的准确性，还存在医生不规范使用POCT 和解读检测结果以及质量控制与管理等影响结果准确性的因素，甚至有可能导致错误的临床决策，因此对POCT 也需要加强质量管理。为规范POCT 技术检测cTn 和BNP/NT-proBNP 在临床的应用，特编写该共识。

 

相关资料下载：
[AttachmentFileName(sort=1, fileName=规范应用心肌肌钙蛋白和利钠肽现场快速检测专家共识_2020年_叶绍东.pdf)] GetToolGuiderByIdResponse(projectId=1, id=a968c1c00202a429, title=规范应用心肌肌钙蛋白和利钠肽现场快速检测专家共识（2020 年）, enTitle=, guiderFrom=中国循环杂志.2020.35(11):1045-1051., authorId=0, author=, summary=国内外多部指南建议使用心肌肌钙蛋白（cTn）和B 型利钠肽（BNP）/N 末端B 型利钠肽原（NT-proBNP）用于急性冠状动脉综合征（ACS）和急、慢性心力衰竭的诊断、鉴别诊断和危险分层，以指导相, cover=https://img.medsci.cn/20201219/1608308810034_2020535.jpg, journalId=0, articlesId=null, associationId=1878, associationName=国家心血管病中心, associationIntro=, copyright=0, guiderPublishedTime=Mon Nov 30 00:00:00 CST 2020, originalUrl=, linkOutUrl=, content=<div class="one_info2" style="color: #373737;"> <div id="all_content"> <div class="editor_mirror editor_mirror_del"> <p>国内外多部指南建议使用心肌肌钙蛋白（cTn）和B 型利钠肽（BNP）/N 末端B 型利钠肽原（NT-proBNP）用于急性冠状动脉综合征（ACS）和急、慢性心力衰竭的诊断、鉴别诊断和危险分层，以指导相关治疗。鉴于胸痛和胸痛等同症状以及胸闷（呼吸困难）是心血管病患者常见症状，而现场快速检测（point-of-care testing,POCT）具有仪器小型化、操作简单化、结果报告即时化（2~10 min 内提供结果）、不受时间与地点限制等优势，本共识优先推荐特异度和灵敏度都较好的POCT 技术检测cTn 和BNP/NT-proBNP 分别作为怀疑ACS 和心力衰竭患者在适宜临床情况下的初诊检测项目。但POCT 在快速获得测试结果、检验周转时间短的情况下，可能会牺牲部分结果的准确性，还存在医生不规范使用POCT 和解读检测结果以及质量控制与管理等影响结果准确性的因素，甚至有可能导致错误的临床决策，因此对POCT 也需要加强质量管理。为规范POCT 技术检测cTn 和BNP/NT-proBNP 在临床的应用，特编写该共识。</p> </div> </div> </div> <div class="box_info" style="color: #373737;">&nbsp;</div>, tagList=[TagDto(tagId=754, tagName=肌钙蛋白)], categoryList=[CategoryDto(categoryId=2, categoryName=心血管, tenant=100), CategoryDto(categoryId=69, categoryName=检验与病理, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=754, guiderKeyword=肌钙蛋白, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=共识, guiderLanguage=0, guiderRegion=3, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=3297, appHits=330, showAppHits=0, pcHits=665, showPcHits=2965, likes=3, shares=36, comments=19, approvalStatus=1, publishedTime=Sat Dec 19 01:18:29 CST 2020, publishedTimeString=2020-11-30, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=2, createdBy=null, createdName=qiushida2, createdTime=Sat Dec 19 00:27:04 CST 2020, updatedBy=2020535, updatedName=qiushida2, updatedTime=Fri Jan 05 16:35:57 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=规范应用心肌肌钙蛋白和利钠肽现场快速检测专家共识_2020年_叶绍东.pdf)])
规范应用心肌肌钙蛋白和利钠肽现场快速检测专家共识_2020年_叶绍东.pdf
下载请点击：
评论区 (17)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1078064, encodeId=859e10e806421, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bd535418836, createdName=ms6000001082899403, createdTime=Wed Dec 08 11:18:34 CST 2021, time=2021-12-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1007423, encodeId=ca7f100e423d2, content=积分, beContent=null, objectType=guider, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210812/426d352aa552429094c8ae32223c1293/f856db0e2d714390aa672d31ab2f151d.jpg, createdBy=9a6b2492830, createdName=12480ee2m89暂无昵称, createdTime=Thu Aug 12 21:54:43 CST 2021, time=2021-08-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1003529, encodeId=3da51003529c3, content=积分不足, beContent=null, objectType=guider, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bd605451105, createdName=ms8000001174036312, createdTime=Thu Jul 29 09:23:22 CST 2021, time=2021-07-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1001953, encodeId=f43d100195396, content=学习了 谢谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7b825555206, createdName=bluesky1977, createdTime=Fri Jul 23 11:04:47 CST 2021, time=2021-07-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=977838, encodeId=f5759e783873, content=好资料，多学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c80a5475761, createdName=ms3000000782886429, createdTime=Tue Jun 29 09:49:00 CST 2021, time=2021-06-29, status=1, ipAttribution=)]
    2021-12-08 ms6000001082899403

    学习了

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1078064, encodeId=859e10e806421, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bd535418836, createdName=ms6000001082899403, createdTime=Wed Dec 08 11:18:34 CST 2021, time=2021-12-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1007423, encodeId=ca7f100e423d2, content=积分, beContent=null, objectType=guider, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210812/426d352aa552429094c8ae32223c1293/f856db0e2d714390aa672d31ab2f151d.jpg, createdBy=9a6b2492830, createdName=12480ee2m89暂无昵称, createdTime=Thu Aug 12 21:54:43 CST 2021, time=2021-08-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1003529, encodeId=3da51003529c3, content=积分不足, beContent=null, objectType=guider, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bd605451105, createdName=ms8000001174036312, createdTime=Thu Jul 29 09:23:22 CST 2021, time=2021-07-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1001953, encodeId=f43d100195396, content=学习了 谢谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7b825555206, createdName=bluesky1977, createdTime=Fri Jul 23 11:04:47 CST 2021, time=2021-07-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=977838, encodeId=f5759e783873, content=好资料，多学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c80a5475761, createdName=ms3000000782886429, createdTime=Tue Jun 29 09:49:00 CST 2021, time=2021-06-29, status=1, ipAttribution=)]
    2021-08-12 12480ee2m89暂无昵称

    积分

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1078064, encodeId=859e10e806421, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bd535418836, createdName=ms6000001082899403, createdTime=Wed Dec 08 11:18:34 CST 2021, time=2021-12-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1007423, encodeId=ca7f100e423d2, content=积分, beContent=null, objectType=guider, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210812/426d352aa552429094c8ae32223c1293/f856db0e2d714390aa672d31ab2f151d.jpg, createdBy=9a6b2492830, createdName=12480ee2m89暂无昵称, createdTime=Thu Aug 12 21:54:43 CST 2021, time=2021-08-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1003529, encodeId=3da51003529c3, content=积分不足, beContent=null, objectType=guider, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bd605451105, createdName=ms8000001174036312, createdTime=Thu Jul 29 09:23:22 CST 2021, time=2021-07-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1001953, encodeId=f43d100195396, content=学习了 谢谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7b825555206, createdName=bluesky1977, createdTime=Fri Jul 23 11:04:47 CST 2021, time=2021-07-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=977838, encodeId=f5759e783873, content=好资料，多学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c80a5475761, createdName=ms3000000782886429, createdTime=Tue Jun 29 09:49:00 CST 2021, time=2021-06-29, status=1, ipAttribution=)]
    2021-07-29 ms8000001174036312

    积分不足

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1078064, encodeId=859e10e806421, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bd535418836, createdName=ms6000001082899403, createdTime=Wed Dec 08 11:18:34 CST 2021, time=2021-12-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1007423, encodeId=ca7f100e423d2, content=积分, beContent=null, objectType=guider, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210812/426d352aa552429094c8ae32223c1293/f856db0e2d714390aa672d31ab2f151d.jpg, createdBy=9a6b2492830, createdName=12480ee2m89暂无昵称, createdTime=Thu Aug 12 21:54:43 CST 2021, time=2021-08-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1003529, encodeId=3da51003529c3, content=积分不足, beContent=null, objectType=guider, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bd605451105, createdName=ms8000001174036312, createdTime=Thu Jul 29 09:23:22 CST 2021, time=2021-07-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1001953, encodeId=f43d100195396, content=学习了 谢谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7b825555206, createdName=bluesky1977, createdTime=Fri Jul 23 11:04:47 CST 2021, time=2021-07-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=977838, encodeId=f5759e783873, content=好资料，多学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c80a5475761, createdName=ms3000000782886429, createdTime=Tue Jun 29 09:49:00 CST 2021, time=2021-06-29, status=1, ipAttribution=)]
    2021-07-23 bluesky1977

    学习了 谢谢

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1078064, encodeId=859e10e806421, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bd535418836, createdName=ms6000001082899403, createdTime=Wed Dec 08 11:18:34 CST 2021, time=2021-12-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1007423, encodeId=ca7f100e423d2, content=积分, beContent=null, objectType=guider, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210812/426d352aa552429094c8ae32223c1293/f856db0e2d714390aa672d31ab2f151d.jpg, createdBy=9a6b2492830, createdName=12480ee2m89暂无昵称, createdTime=Thu Aug 12 21:54:43 CST 2021, time=2021-08-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1003529, encodeId=3da51003529c3, content=积分不足, beContent=null, objectType=guider, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bd605451105, createdName=ms8000001174036312, createdTime=Thu Jul 29 09:23:22 CST 2021, time=2021-07-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1001953, encodeId=f43d100195396, content=学习了 谢谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7b825555206, createdName=bluesky1977, createdTime=Fri Jul 23 11:04:47 CST 2021, time=2021-07-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=977838, encodeId=f5759e783873, content=好资料，多学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c80a5475761, createdName=ms3000000782886429, createdTime=Tue Jun 29 09:49:00 CST 2021, time=2021-06-29, status=1, ipAttribution=)]
    2021-06-29 ms3000000782886429

    好资料，多学习

    0

以上为热门评论，梅斯医学App还有更多内容

相关指南

急性冠状动脉综合征患者检测心肌肌钙蛋白的专家共识

中华医学会心血管病学分会(Chinese Society of Cardiology) · 2017-04-25

拓展阅读

急性冠状动脉综合征患者检测心肌肌钙蛋白的专家共识

中华医学会心血管病学分会(Chinese Society of Cardiology) · 2017-04-25